Cardiology Conferences

The global cardiology market includes interventional and cardiovascular devices. By 2020, the global interventional cardiology devices market has been expected to grasp $25.16 billion. On the other hand, the Asia Pacific market is expected to go above $6.4 billion by 2022, growing at a lucrative rate over the forecast period. From 2010 to 2015, the global market for cardiovascular surgical devices used in the operating room costs increased almost $17 billion at a CAGR of 8.7%. By 2017, it is estimated to reach at a market value of $70. Presence of large initial opportunities, rising healthcare expense, cardiovascular disease incidence rate and disposable income levels are the main reason for growth attribution. North America interventional cardiology devices market was the largest with revenue share estimated at over 35.0% in 2013. Europe was the second biggest area in 2014, with rising occurrences of obesity and changing lifestyle habits as, irregularities in diet and evolving number of smokers are responsible for the happening of cardiovascular disease prevalence. The advance of these products in this region also depends on the restitution policies given by each of the European nations. Growth at a CAGR of over 9.0% from 2014 to 2020 has been observed for the Asia Pacific interventional cardiology devices market due to the increasing popularity of cardiovascular disorders in geriatric and pediatric population, growing awareness about the cost efficacy and efficiency provided by these devices and rising health care expenditure levels.